This course has expired. View available courses.
Infectious Disease
(Pharmacy) Optimizing Influenza Immunization for Older Adults
This program helps clinicians optimize influenza immunization for adults aged ≥65 years old. The program will review the influenza burden in this population, the types of adverse outcomes experienced by older adults, and how to prevent adverse outcomes with vaccination.
DURATION
30 min
PROFESSION
Pharmacy
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-12-31
Individuals aged 65 years and older are at an increased risk for more detrimental effects of influenza.
This program helps clinicians optimize influenza immunization for adults aged ≥65 years old. The program will review the influenza burden in this population, the types of adverse outcomes experienced by older adults, and how to prevent adverse outcomes with vaccination.
Using a case study, the program will also compare the different vaccines indicated for this population and discuss the National Advisory Committee on Immunization (NACI) and Advisory Committee on Immunization Practices (ACIP) recommendations as well as the available real-world vaccine effectiveness data for influenza vaccines in adults ≥ 65 years old.
This program is made possible through educational support from CSL Seqirus.
Faculty
Melissa Andrew, MD, MSc Public Health, PhD, FRCPC
Anas Nseir, MD
Shelley Ross, MD
Sofia Nastis, MD, CCFP
Stephane Villeneuve, Pharm. D.
Carlene Oleskyn, B.S.P., R.Ph, CTH, CDE
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Discuss the burden of influenza in adults ≥65 years old
- Review the strains that cause the most influenza in adults ≥65 years old
- Compare the influenza vaccines indicated for adults ≥65 years old and discuss NACI and ACIP recommendations for this population
- Describe the available Real World Vaccine Effectiveness data for influenza vaccines in adults ≥65 years old
Accreditation
#
of credits: 0
Duration: 30 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Pharmacy
Profession
0
# of credits
Learning Objectives
Upon
completion of this continuing education program participants will be better
able to:
- Discuss
the burden of influenza in adults ≥65 years old - Review
the strains that cause the most influenza in adults ≥65
years
old - Compare
the influenza vaccines indicated for adults ≥65 years old and discuss NACI and ACIP
recommendations for this population - Describe
the available Real World Vaccine Effectiveness data for influenza vaccines in
adults ≥65
years
old
Unaccredited
ACCREDITATION
Infectious Disease
Learning Category
Influenza, Vaccinations
Topic
0
Price
2023-12-31
Expiry Date
CAN-eng
Region/Language
Course Description
Individuals aged 65 years and older are at an increased risk for more detrimental effects of influenza.
This program helps clinicians optimize influenza immunization for adults aged ≥65 years old. The program will review the influenza burden in this population, the types of adverse outcomes experienced by older adults, and how to prevent adverse outcomes with vaccination.
Using a case study, the program will also compare the different vaccines indicated for this population and discuss the National Advisory Committee on Immunization (NACI) and Advisory Committee on Immunization Practices (ACIP) recommendations as well as the available real-world vaccine effectiveness data for influenza vaccines in adults ≥ 65 years old.
This program is made possible through educational support from CSL Seqirus.
Faculty
Melissa Andrew, MD, MSc Public Health, PhD, FRCPC
Anas Nseir, MD
Shelley Ross, MD
Sofia Nastis, MD, CCFP
Stephane Villeneuve, Pharm. D.
Carlene Oleskyn, B.S.P., R.Ph, CTH, CDE
Accreditation
<!–
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 0.5 CEU(s).
CCCEP File Number: 1066-2022-3539-I-P
30 min
Duration
0
Price
0
# of credits
